30389923 |
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
Vellano, CP,
Scott, KL,
Ju, Z,
Jeong, KJ,
Shao, SH,
Leonard, PG,
Woessner, R,
Mills, GB,
Sahni, N,
Ip, CKM,
Hua, X,
Ng, PKS
|
Nat Commun |
2018 |
29408302 |
The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders
Roskoski, R
|
Pharmacol. Res. |
2018 |
12522257 |
PDGFRA activating mutations in gastrointestinal stromal tumors
Corless, CL,
Heinrich, MC,
Singer, S,
Griffith, DJ,
Town, A,
Haley, A,
Duensing, A,
McGreevey, L,
Fletcher, JA,
Demetri, GD,
Joseph, N,
Chen, CJ,
Fletcher, CD
|
Science |
2003 |
12949711 |
Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors
Kitamura, Y,
Shinomura, Y,
Isozaki, K,
Nishida, T,
Kinoshita, K,
Ohashi, A,
Hirota, S
|
Gastroenterology |
2003 |
28351781 |
GEIS guidelines for gastrointestinal sarcomas (GIST)
Romero, I,
Martín-Broto, J,
López-Guerrero, JA,
Grupo Español de Investigación en Sarcomas/Spanish Group for Sarcoma Research, -,
Martínez, V,
Valverde, C,
Poveda, A,
García Del Muro, X,
Cubedo, R,
Serrano, C
|
Cancer Treat. Rev. |
2017 |
29964125 |
Structural and clinical consequences of activation loop mutations in class III receptor tyrosine kinases
Heinrich, MC,
Kent, JD,
Klug, LR
|
Pharmacol. Ther. |
2018 |
15928335 |
PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib
Shiraga, S,
McGreevey, L,
Schroeder, A,
Corless, CL,
Heinrich, MC,
Harrell, P,
Morich, J,
Bainbridge, T,
Town, A,
Griffith, D
|
J. Clin. Oncol. |
2005 |
23752188 |
PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutations
Polyansky, AA,
Hallberg, B,
Van Cauwenberghe, S,
Demoulin, JB,
Montano-Almendras, CP,
Chand, D,
Velghe, AI,
Essaghir, A,
Charni, S
|
Oncogene |
2014 |